Clorox Co. (NYSE:CLX) shares dropped 1.2% during trading on Tuesday . The company traded as low as $135.60 and last traded at $136.00, with a volume of 443,329 shares trading hands. The stock had previously closed at $137.71.

CLX has been the topic of a number of research analyst reports. Zacks Investment Research lowered Clorox from a “buy” rating to a “hold” rating in a report on Wednesday, April 6th. B. Riley reissued a “neutral” rating and set a $109.00 price target (up from $102.00) on shares of Clorox in a report on Thursday, May 5th. Barclays PLC raised their price target on Clorox from $112.00 to $120.00 and gave the company an “underweight” rating in a report on Monday, March 21st. Atlantic Securities initiated coverage on Clorox in a report on Tuesday, June 14th. They set a “neutral” rating and a $138.00 price target on the stock. Finally, Goldman Sachs Group Inc. raised their price target on Clorox from $125.00 to $126.00 and gave the company a “neutral” rating in a report on Tuesday, May 3rd. Three analysts have rated the stock with a sell rating and seven have given a hold rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $124.10.

The firm has a 50-day moving average price of $133.02 and a 200 day moving average price of $128.82. The company has a market cap of $17.62 billion and a PE ratio of 26.62.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Tuesday, May 3rd. The company reported $1.21 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.11 by $0.10. During the same period in the prior year, the firm earned $1.08 EPS. The company earned $1.43 billion during the quarter, compared to analyst estimates of $1.41 billion. Clorox’s quarterly revenue was up 1.8% compared to the same quarter last year. Equities analysts expect that Clorox Co. will post $4.95 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 12th. Shareholders of record on Wednesday, July 27th will be paid a $0.80 dividend. This represents a $3.20 dividend on an annualized basis and a yield of 2.32%. This is a boost from Clorox’s previous quarterly dividend of $0.77. The ex-dividend date is Monday, July 25th.

In other Clorox news, COO Nikolaos A. Vlahos sold 2,151 shares of the business’s stock in a transaction on Tuesday, May 10th. The stock was sold at an average price of $132.25, for a total value of $284,469.75. Following the transaction, the chief operating officer now owns 13,883 shares of the company’s stock, valued at $1,836,026.75. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

A number of institutional investors have bought and sold shares of the company. Vanguard Group Inc. raised its position in Clorox by 2.2% in the fourth quarter. Vanguard Group Inc. now owns 12,819,276 shares of the company’s stock worth $1,625,869,000 after buying an additional 273,177 shares in the last quarter. Old Mutual Global Investors UK Ltd. acquired a new position in Clorox during the fourth quarter worth approximately $15,492,000. Navellier & Associates Inc raised its position in Clorox by 4,376.5% in the fourth quarter. Navellier & Associates Inc now owns 116,614 shares of the company’s stock worth $14,790,000 after buying an additional 114,009 shares in the last quarter. Wells Fargo & Company MN raised its position in Clorox by 2.5% in the fourth quarter. Wells Fargo & Company MN now owns 3,493,620 shares of the company’s stock worth $443,096,000 after buying an additional 85,557 shares in the last quarter. Finally, Bank of Montreal Can raised its position in Clorox by 25.1% in the fourth quarter. Bank of Montreal Can now owns 331,941 shares of the company’s stock worth $42,102,000 after buying an additional 66,591 shares in the last quarter.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.